Novozymes A/S (LON:0Q4U)

Market Cap	20.90B +0.4%
Revenue (ttm)	3.62B +19.3%
Net Income	477.46M +74.4%
EPS	1.67 +151.6%
Shares Out	n/a
PE Ratio	43.77
Forward PE	24.88
Dividend	0.74 (0.19%)
Ex-Dividend Date	Aug 25, 2025

Volume	109,402
Average Volume	67,181
Open	384.95
Previous Close	386.35
Day's Range	381.00 - 386.80
52-Week Range	368.60 - 489.10
Beta	0.78
RSI	41.12
Earnings Date	Feb 25, 2026

About Novozymes

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional lau...

• Industry: Miscellaneous Chemical Products
• Founded: 1925
• Employees: 10,582
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q4U

Financial Performance

In 2024, Novozymes's revenue was 3.83 billion, an increase of 59.58% compared to the previous year's 2.40 billion. Earnings were 305.80 million, a decrease of -24.66%.

Financial numbers in EUR